Highest Dividend yield of Pharmaceuticals and Biotechnology stocks




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Dividend yield of Pharmaceuticals and Biotechnology companies ordered from highest ( 1.55% average).

Company Dividend Payout Country
GlaxoSmithKline4.82%228.57%UK
AstraZeneca4.47%71.66%UK
Teva Pharmaceutical4.15%123.50%Israel
AbbVie Inc3.93%61.69%USA
Pfizer3.74%68.82%USA
Novartis (REGD)3.70%66.27%Switzerland
Sanofi3.46%57.45%France
Takeda Pharm3.44%67.42%Japan
Roche Hldgs (GENUS)3.21%62.58%Switzerland
Novo-Nordisk B3.17%50.70%Denmark
Gilead Sciences3.06%19.00%USA
Merck & Co2.96%68.36%USA
Bristol Myers Squibb2.87%56.32%USA
Amgen Corp2.80%37.20%USA
Daiichi Sankyo2.79%47.16%Japan
Orion B2.76%76.70%Finland
Eisai2.60%17.16%Japan
Johnson & Johnson2.57%49.61%USA
KYORIN Holdings2.47%31.37%Japan
Lilly (Eli) & Co2.47%67.31%USA
Abbott Laboratories2.39%94.64%USA
Kaken Pharmaceutical2.38%29.04%Japan
Astellas Pharmaceuti2.32%30.16%Japan
Miraca Holdings2.23%-128.00%Japan
Sawai Pharmaceutical2.16%27.86%Japan
Mitsubishi Tanabe Ph2.07%47.81%Japan
Otsuka Holdings1.99%58.51%Japan
TORRENT PHARMACEUTIC1.93%27.02%India
Shanghai Pharmaceuti1.91%27.66%China
Tsumura & Co1.83%34.96%Japan
Grifols S.A. Cl B1.78%34.83%Spain
Alfresa Holdings1.76%21.12%Japan
Ono Pharmaceutical1.74%79.69%Japan
Medipal Holdings1.72%22.01%Japan
Santen Pharm1.61%17.71%Japan
Divis Laboratories1.60%23.84%India
China Medical System1.59%45.83%China
Kissei Pharm1.58%27.33%Japan
UCB Cap1.51%30.56%Belgium and Lux.
China Traditional Ch1.50%31.58%China
Suzuken1.48%18.06%Japan
Novozymes A/S1.45%35.55%Denmark
Kyowa Hakko Kirin1.42%73.42%Japan
Wockhardt1.39%32.26%India
CSL1.38%45.05%Australia
Grifols1.36%34.83%Spain
Chugai Seiyaku1.36%51.41%Japan
Sinopharm Group (H)1.34%29.63%China
Mochida Pharm1.33%26.73%Japan
Shanghai Fosun Pharm1.32%30.40%China
Lonza Grp Ag N1.32%47.53%Switzerland
Hisamitsu Pharmaceut1.27%37.97%Japan
Livzon Pharmaceutical Group1.23%30.77%China
Kalbe Farma1.23%43.54%Indonesia
Taisho Pharmaceutica1.22%39.16%Japan
Shionogi1.18%30.92%Japan
Chr. Hansen Holding1.17%44.14%Denmark
Hikma Pharmaceutical1.16%33.33%UK
Richter1.10%21.23%Hungary
Recordati1.10%27.56%Italy
CSPC Pharmaceutical1.08%39.29%China
Rohto Pharmaceutical1.01%25.15%Japan
Merck Kgaa0.98%15.72%Germany
Sumitomo Dainippon P0.98%23.32%Japan
Perrigo Company plc0.96%11.29%USA
Kobayashi Pharmaceut0.95%30.21%Japan
Sino Biopharm (P Chi0.94%25.00%China
Piramal Enterprises0.92%27.24%India
Ipsen0.91%28.62%France
Aspen Pharmacare Hol0.90%22.93%South Africa
Yuhan0.86%12.64%Korea
Hanmi Science0.80%0.00%Korea
Luye Pharma Group (P0.79%14.29%China
Zoetis0.79%22.95%USA
China National Accor0.78%14.23%China
H. Lundbeck0.76%20.99%Denmark
Dr Reddys Labs0.76%14.44%India
Cadila Healthcare0.72%21.07%India
Nippon Shinyaku0.65%39.20%Japan
Hanmi Pharmaceutical0.63%0.00%Korea
Actelion Hldg N0.53%20.69%Switzerland
Lupin0.52%14.52%India
Shire0.52%16.33%UK
Aurobindo Pharmaceut0.39%7.56%India
Cipla0.34%10.56%India
Allergan0.29%1.10%USA
Glenmark Pharmaceuti0.23%6.56%India
Sun Pharmaceuticals0.15%5.01%India
Qiagen Nv0.00%0.00%Germany
Valeant Pharmaceutic0.00%0.00%Canada
3SBio (P Chip)0.00%0.00%China
Guangzhou Baiyunsha0.00%0.00%China
Genmab0.00%0.00%Denmark
Peptidream0.00%0.00%Japan
Celltrion Inc0.00%0.00%Korea
Samsung Biologics0.00%0.00%Korea
OBI Pharma0.00%0.00%Taiwan
Alexion Pharm0.00%0.00%USA
Alkermes plc0.00%0.00%USA
Biogen0.00%0.00%USA
BioMarin Pharm0.00%0.00%USA
Bioverativ0.00%0.00%USA
Celgene Corp0.00%0.00%USA
Endo International p0.00%0.00%USA
Illumina Inc0.00%0.00%USA
Incyte0.00%0.00%USA
Jazz Pharmaceuticals0.00%0.00%USA
Mallinckrodt plc0.00%0.00%USA
Mylan N.V.0.00%0.00%USA
Quintiles Transnatio0.00%0.00%USA
Regeneron Phar0.00%0.00%USA
Vertex Pharm0.00%0.00%USA
Alnylam Pharmaceutic0.00%0.00%USA
Medivation0.00%0.00%USA
Adcock Ingram Holdin2.74%88.51%South Africa
Meda A1.57%21.55%Sweden
GlaxoSmithKline Phar1.51%111.59%India

 


 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.